144 related articles for article (PubMed ID: 1706386)
1. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
Rayhel EJ; Dehoff MH; Holers VM
J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
[TBL] [Abstract][Full Text] [Related]
2. Identification of 5'-regions affecting the expression of the human CR2 gene.
Yang LM; Behrens M; Weis JJ
J Immunol; 1991 Oct; 147(7):2404-10. PubMed ID: 1833454
[TBL] [Abstract][Full Text] [Related]
3. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
[TBL] [Abstract][Full Text] [Related]
4. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
5. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).
Fingeroth JD
J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457
[TBL] [Abstract][Full Text] [Related]
6. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
Christensen SM; Martin BK; Tan SS; Weis JH
J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein.
Tolnay M; Lambris JD; Tsokos GC
J Immunol; 1997 Dec; 159(11):5492-501. PubMed ID: 9548489
[TBL] [Abstract][Full Text] [Related]
9. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
Carel JC; Frazier B; Ley TJ; Holers VM
J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
[TBL] [Abstract][Full Text] [Related]
11. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH
J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587
[TBL] [Abstract][Full Text] [Related]
12. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
Barel M; Gauffre A; Lyamani F; Fiandino A; Hermann J; Frade R
J Immunol; 1991 Aug; 147(4):1286-91. PubMed ID: 1831222
[TBL] [Abstract][Full Text] [Related]
13. Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations.
Holguin MH; Kurtz CB; Parker CJ; Weis JJ; Weis JH
J Immunol; 1990 Sep; 145(6):1776-81. PubMed ID: 2144008
[TBL] [Abstract][Full Text] [Related]
14. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
[TBL] [Abstract][Full Text] [Related]
15. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
Cantaloube JF; Piechaczyk M; Calender A; Lenoir G; Minty A; Carrière D; Fischer E; Poncelet P
Eur J Immunol; 1990 Feb; 20(2):409-16. PubMed ID: 1690137
[TBL] [Abstract][Full Text] [Related]
16. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element.
Cui W; Hourcade D; Post T; Greenlund AC; Atkinson JP; Kumar V
J Immunol; 1993 Oct; 151(8):4137-46. PubMed ID: 7691939
[TBL] [Abstract][Full Text] [Related]
18. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
Ying H; Chang JF; Parnes JR
J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the expression and gene promoter of CD22 in murine B cells.
Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
